Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study

Shun Lü, Yiping Zhang, Guojun Zhang, Jianying Zhou, Shundong Cang, Ying Cheng, Gang Wu, Peiguo Cao, Dongqing Lv, Hong Jian, Chengshui Chen, Xiangming Jin, Panwen Tian, Kai Wang, Guanming Jiang, Gongyan Chen, Qun Chen, Hui Zhao, Cuimin Ding, Renhua Guo, Guoping Sun, Bin Wang, Liyan Jiang, Zhe Liu, Jian Fang, Junquan Yang, Wu Zhuang, Yunpeng Liu, Jian Zhang, Yueyin Pan, Jun Chen, Qitao Yu, Min Zhao, Jiuwei Cui, Dianming Li, Tienan Yi, Zhuang Yu, Yan Yang, Yan Zhang, Xiuyi Zhi, Yunchao Huang, Rong Wu, Liangan Chen, Aimin Zang, Lejie Cao, Qingshan Li, Xiaoling Li, Yong Song, Donglin Wang, Shucai Zhang, Lieming Ding, Ling Zhang, Xiaobin Yuan, Lin Yao, Zhilin Shen